INFINIUM logo

Infinium Pharmachem LTD

INFINIUM·NSE·
260.00 -1.70 (-0.65%)
Market Cap347.43 Cr
PE Ratio33.33
Volume2,500
Day High - Low261.50 - 255.00
52W High-Low282.90 - 189.40
DocStoX Score
5.7/10
Fair
Fair Value
Sign in to see
ROE
10.50%
Average
P/E
33.33x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day255.00
261.50
52W189.40
282.90
DocStoX take

Supported by growth (8.5) and momentum (7.5), but held back by valuation (1.8). Growth looks strong at 8.5, but that is offset by valuation at 1.8. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.7
/10
Fair
Quality
Modest
ROE 10.5%
Valuation
Expensive
P/E 33.3×
Growth
Strong
Revenue +21.8% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
Strong
76% of 52-week range

At a glance

Market Cap
₹347 Cr
52W High / Low
₹283 / ₹189
Dividend Yield
0.00%
Promoter Holding
64.91%
EPS (TTM)
₹7.80
Book Value
₹77.70

Key highlights

  • Profit compounding 36% a year
  • Low leverage — D/E 0.00
  • Profitable in all of the last 5 years
  • Valuation is weak (1.8/10)
  • Small ₹347 cr company — thinner liquidity
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

INFINIUM PHARMACHEM LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.